NCT07473843Phase 3Recruiting

Study of Zodasiran in Adolescent Participants With Homozygous Familial Hypercholesterolemia

Study sponsor: Arrowhead Pharmaceuticals

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2028-07Estimated
Enrollment · participants10Estimated
Source updated2026-10-26Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Recruitment status changed

Before: Not yet recruiting. After: Recruiting.

Check registry source

· 1 field changed

Planned enrollment decreased by 2 participants

Before: 12 participants (planned). After: 10 participants (planned).

Check registry source